Clearside Biomedical Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Clearside Biomedical Stock Summary

Clearside Biomedical competes with Capricor Therapeutics, Akari Therapeutics, Soleno Therapeutics, Bio Path, and Moleculin Biotech. Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia. Clearside Biomedi operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 34 people.

Clearside Biomedical Key Financial Ratios

Clearside Biomedical Key Balance Sheet Accounts

Clearside Biomedical Key Income Statement Accounts

Clearside Biomedical Key Cash Accounts

Clearside Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Clearside Biomedical's current stock value. Our valuation model uses many indicators to compare Clearside Biomedical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Clearside Biomedical competition to find correlations between indicators driving Clearside Biomedical's intrinsic value. More Info.Clearside Biomedical is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Clearside Biomedical's Return On Equity is projected to increase significantly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Clearside Biomedical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Clearside Biomedical Systematic Risk

Today, most investors in Clearside Biomedical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Clearside Biomedical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Clearside Biomedical growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Clearside Biomedical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Clearside Biomedical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Clearside Biomedical based on widely used predictive technical indicators. In general, we focus on analyzing Clearside Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Clearside Biomedical's daily price indicators and compare them against related drivers.

When running Clearside Biomedical's price analysis, check to measure Clearside Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearside Biomedical is operating at the current time. Most of Clearside Biomedical's value examination focuses on studying past and present price action to predict the probability of Clearside Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearside Biomedical's price. Additionally, you may evaluate how the addition of Clearside Biomedical to your portfolios can decrease your overall portfolio volatility.